31 October 2013
ELPEN's strategic global expansion spearheaded by the ground-breaking device: Elpenhaler®
ELPEN drugs are exported to 60 countries worldwide, 27 of which are in Europe, with the primary aim to achieve further global expansion, spearheaded by Elpenhaler®, an original product, patented by the company's founder, Mr. Dimitrios Pentafragas.